Streetbeat News

Marketing

EGRX

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced it will present a Trial in Progress on its Phase 2/3 study of intravenous amisulpride for preventing postoperative nausea and vomiting in pediatric patients at the SAMBA 2024 Annual Meeting. The study targets patients from birth to 17 years and aims to share preliminary results in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:06 pm

ROKU

TTD

Roku and The Trade Desk have announced a new partnership aimed at enhancing data-driven TV streaming advertising. This collaboration will leverage Roku's extensive streaming platform and The Trade Desk's advertising technology to offer advertisers more targeted and effective advertising solutions. The partnership is expected to benefit both companies by expanding their advertising capabilities and potentially increasing their revenue from ad sales.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:01 pm

GRTS

Gritstone Bio presented data at ESCMID Global 2024 showcasing the durability and broad utility of its self-amplifying mRNA COVID-19 vaccine, indicating potential for widespread application and long-term effectiveness.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:16 am

ACB

Aurora has expanded its product line in Australia by introducing a new range of premium dried flower products, aiming to strengthen its market presence.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:16 am

ALNY

Medison and Alnylam Pharmaceuticals have expanded their partnership to commercialize RNAi therapeutics in additional markets in Latin America (LATAM) and the Asia-Pacific (APAC) region, building on their existing collaboration in Europe and Israel.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:06 am

META

MSFT

The 'GPT2-Chatbot' has recently gained attention for potentially outperforming OpenAI's GPT-4 in various tasks, including solving an International Math Olympiad problem and complex reasoning tasks. OpenAI CEO Sam Altman expressed a 'soft spot' for GPT2, hinting at its significance. Amidst speculation about its origins, some believe it could be an OpenAI creation, while others think it might come from a different entity. This development occurs as OpenAI prepares to launch GPT-5, expected to be a major upgrade over GPT-4, with Microsoft possibly integrating it into its Copilot Pro subscription. Meanwhile, Meta Platforms has introduced its Llama 3 model, claiming superior performance in benchmarks, though GPT-4 was not included in its comparisons.

Portfolio Pulse from Rounak Jain

April 30, 2024 | 10:38 am

BJ

BJ's Wholesale Club has announced the opening of new locations in Florida and New York, expanding its presence in these key markets. This expansion is part of BJ's ongoing strategy to increase its market share and reach more customers in the United States.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:32 am

WMT

Walmart has introduced a new private brand named bettergoods, aimed at providing elevated culinary experiences at accessible prices. This move is part of Walmart's strategy to enhance its product offerings and attract a broader customer base by offering high-quality, affordable culinary products.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:08 am

NTES

NetEase Cloud Music has entered into an agreement with JYP Entertainment to expand its K-Pop music portfolio for Chinese audiences. The partnership aims to leverage both companies' strengths to promote JYP Entertainment's K-Pop artists and explore new commercial opportunities.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:18 am

NFLX

The Netflix series 'Drive to Survive' has significantly diversified and expanded Formula One's fanbase, attracting a more diverse and younger audience, including a notable increase in female fans. The show's success in popularizing F1, especially in the U.S., has contributed to Netflix's continued subscriber growth, despite recent price hike concerns. Analysts predict a potential for over 25% upside in Netflix's stock due to its strong performance and the monetization potential of its original content.

Portfolio Pulse from Benzinga Neuro

April 30, 2024 | 6:49 am